Daniel Bogdanovic Email & Phone Number

Washington D.C. Metro Area

• Supporting the strategic direction, implementation and evaluation of a wide-scale data analytics architecture initiative for a major US Health Insurero Managing multiple technical work-streams related to the delivery of a key reporting tool as part of the organization’s new data analytics architecture including overseeing the end-to-end SDLC process, facilitating working sessions with stakeholders, and identifying/mitigating program risks and issues. o Developed an Operational reporting framework to provide advanced BI analytics to Senior Leadership on the adoption and performance of the reporting tools comprising the new data analytics architecture.

London, United Kingdom

• Quantitatively estimated and modelled the costs/benefits of two major social policy initiatives in KSA (‘Impact of Policy Change’, Ministry of Health, Kingdom of Saudi Arabia, 2018 – details confidential) using econometric techniques to support and inform policy recommendations for government representatives • Supported the design of a Saudi Arabian healthcare transformation strategy by analysing clinical activity data for stroke/trauma/ACS in the Kingdom and identifying pain points in the current patient pathways o Translated pain point analysis into an actionable plan for transformative change, in collaboration with senior officials within the Ministry of Health • Independently conducted Kaplan-Meier survival analysis to data from a four-year study conducted by a large US medical devices company to test for statistical differences in outcomes between two cohort groups o Aggregated and analysed Medicare/Medicaid data using R to determine clinical effectiveness/benefit to system of medical intervention and presented findings to board of directors. • Produced a validated and tested framework for future hearing research prioritistation in the NHS by disseminating a Delphi survey to experts globally to understand current research gaps, analysing the outputs using mathematical techniques to measure consensus and then testing the findings with an NHS steering group.

London, United Kingdom

• Collaborated with Client Markets to investigate the market for an up-and-coming alternative to private medical insurance and assess the potential business opportunity for Swiss Re. o Independently presented findings to the Head of Life and Health products for the EMEA region. • Forecasted future inpatient and outpatient costs associated with Swiss Re’s corporate medical insurance portfolios using a combination of historic claims data and interest rate trends.